Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions

E-ISSN： 1873-5592|17|2|206-228

ISSN： 1389-4501

Source： Current Drug Targets, Vol.17, Iss.2, 2016-02, pp. : 206-228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advances in Nanocarriers for Anticancer Drugs Delivery

Current Medicinal Chemistry, Vol. 23, Iss. 20, 2016-08 ,pp. : 2159-2187

Bentham Science Publishers

Access to resources Recommend Favorite

Nanocarriers for Anticancer Drugs - New Trends in Nanomedicine

Current Drug Metabolism, Vol. 14, Iss. 5, 2013-06 ,pp. : 547-564

Bentham Science Publishers

Access to resources Recommend Favorite

Nanocarriers for the Simultaneous Co-Delivery of Therapeutic Genes and Anticancer Drugs

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 7, 2012-06 ,pp. : 1317-1331

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Drug Delivery Systems for Sustained and Targeted Delivery of Anti-Cancer Drugs: Current Status and Future Prospects

Current Drug Delivery, Vol. 7, Iss. 2, 2010-04 ,pp. : 152-161

Bentham Science Publishers

Access to resources Recommend Favorite

Current Status and Future Perspectives of PI3K and mTOR Inhibitor as Anticancer Drugs in Breast Cancer

Current Cancer Drug Targets, Vol. 13, Iss. 2, 2013-02 ,pp. : 175-187

Bentham Science Publishers

Access to resources Recommend Favorite